We found that the mRNA expression of C4ORF3 was significantly lower in people with grade 3 obesity (BMI > 40) and obese individuals with type 2 diabetes relative to non-obese healthy people (Figure 6A). This evidence concerns the gene ARLN and obesity disorder.